Germany· DE-A57-1a4c1fab8c08f365

Ultracain

A articaine product containing articaine hydrochloride, registered in Germany by Septodont Gmbh. The same ATC class is registered in 2 of our 19 countries.

ATC N01BB08

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedUltracainATCN01BB08REGISTER NO.DE-A57-1a4c1fab8c08f3…PACKS LISTED0CHECKEDAugust 5, 2026

Where it is registered

Articaine is registered in 2 of 19 countries.

Countries holding a registration under ATC N01BB08 (articaine), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 1 of them publish a price we can compare per daily dose

Articaine · ATC N01BB08

2 / 19 countries

  • Germany
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

EMA Article 57 (European Union)
Active substance
Articaine Hydrochloride
Manufacturer
Septodont Gmbh
Country
Germany (DE)
ATC code
N01BB08
ATC class
Articaine
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
August 5, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

22 interactions on record for articaine.

Graded by severity as the source publishes them — 21 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Articaine · interactions on record

22 records

  • 21 moderate
  • 1 minor

Most severe, free to view

  • LidocainA01AE01moderate
  • TetracainA01AE02moderate
  • LidocaineC05AD01moderate
  • TetracaineC05AD02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Articaine in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All articaine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c3cf0af0-b54a-4836-b24c-36600941c736
GET /v1/drugs/c3cf0af0-b54a-4836-b24c-36600941c736?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Epidural Use, Infiltration, Intravenous Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Articaine Hydrochloride",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

See everything about articaine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.